207 related articles for article (PubMed ID: 9606814)
1. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma.
Celli A; Que FG
Semin Liver Dis; 1998; 18(2):177-85. PubMed ID: 9606814
[TBL] [Abstract][Full Text] [Related]
2. New insights on the molecular and cell biology of human cholangiopathies.
Alvaro D; Mancino MG
Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
[TBL] [Abstract][Full Text] [Related]
3. [Physiologic and pathologic experimental models for studying cholangiocytes].
Lee SO
Korean J Hepatol; 2008 Jun; 14(2):139-49. PubMed ID: 18617761
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of novel aspects of biliary pathophysiology.
Marzioni M; Saccomanno S; Candelaresi C; Rychlicki C; Agostinelli L; Trozzi L; De Minicis S; Benedetti A
Dig Liver Dis; 2010 Apr; 42(4):238-44. PubMed ID: 20167547
[TBL] [Abstract][Full Text] [Related]
5. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes.
Hohenester S; Wenniger LM; Paulusma CC; van Vliet SJ; Jefferson DM; Elferink RP; Beuers U
Hepatology; 2012 Jan; 55(1):173-83. PubMed ID: 21932391
[TBL] [Abstract][Full Text] [Related]
6. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
Pinto C; Giordano DM; Maroni L; Marzioni M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
[TBL] [Abstract][Full Text] [Related]
7. The pathobiology of biliary epithelia.
Roberts SK; Ludwig J; Larusso NF
Gastroenterology; 1997 Jan; 112(1):269-79. PubMed ID: 8978368
[TBL] [Abstract][Full Text] [Related]
8. The pathobiology of biliary epithelia.
Alpini G; McGill JM; Larusso NF
Hepatology; 2002 May; 35(5):1256-68. PubMed ID: 11981776
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line.
Harnois DM; Que FG; Celli A; LaRusso NF; Gores GJ
Hepatology; 1997 Oct; 26(4):884-90. PubMed ID: 9328309
[TBL] [Abstract][Full Text] [Related]
10. Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated rats.
Svegliati-Baroni G; Ghiselli R; Marzioni M; Alvaro D; Mocchegiani F; Saccomanno S; Sisti V; Ugili L; Orlando F; Alpini G; Saba V; Benedetti A
J Hepatol; 2006 Jun; 44(6):1158-66. PubMed ID: 16481066
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical features of bile duct epithelial cells in normal and experimental liver conditions.
Onori P; Franchitto A; Alvaro D; Gaudio E
Ital J Anat Embryol; 2001; 106(2 Suppl 1):371-8. PubMed ID: 11729979
[TBL] [Abstract][Full Text] [Related]
12. [Inflammatory and neoplastic cholangiopathies.].
Alvaro D; Bragazzi MC; Ridola L
Recenti Prog Med; 2018 Dec; 109(12):595-599. PubMed ID: 30667389
[TBL] [Abstract][Full Text] [Related]
13. Biliary brushing cytology.
Selvaggi SM
Cytopathology; 2004 Apr; 15(2):74-9. PubMed ID: 15056166
[TBL] [Abstract][Full Text] [Related]
14. erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer.
Lai GH; Zhang Z; Shen XN; Ward DJ; Dewitt JL; Holt SE; Rozich RA; Hixson DC; Sirica AE
Gastroenterology; 2005 Dec; 129(6):2047-57. PubMed ID: 16344070
[TBL] [Abstract][Full Text] [Related]
15. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells.
Yokomuro S; Tsuji H; Lunz JG; Sakamoto T; Ezure T; Murase N; Demetris AJ
Hepatology; 2000 Jul; 32(1):26-35. PubMed ID: 10869285
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
Bickenbach K; Galka E; Roggin KK
Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and benign biliary tract diseases.
Gradilone SA; O'Hara SP; Masyuk TV; Pisarello MJ; LaRusso NF
Semin Liver Dis; 2015 Feb; 35(1):26-35. PubMed ID: 25632932
[TBL] [Abstract][Full Text] [Related]
19. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma.
Chen RF; Li ZH; Zou SQ; Chen JS
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):71-4. PubMed ID: 15730924
[TBL] [Abstract][Full Text] [Related]
20. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
